Biodistribution and radiation dosimetry of radioiodinated hypericin as a cancer therapeutic

Metabolic Drug Interactions Between Antidepressants and Anticancer Drugs: Focus on Selective Serotonin Reuptake Inhibitors and Hypericum Extract

(2013) Filippo Caraci et al.   CURRENT DRUG METABOLISM

Improved clearance of radioiodinated hypericin as a targeted anticancer agent by using a duodenal drainage catheter in rats

(2013) Marlein Miranda Cona et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Clinical, Safety, and Economic Evidence in Radioactive Iodine–Refractory Differentiated Thyroid Cancer: A Systematic Literature Review

(2013) Roger T. Anderson et al.   THYROID

A safety study on single intravenous dose of tetrachloro-diphenyl glycoluril [iodogen] dissolved in dimethyl sulphoxide (DMSO)

(2013) Marlein Miranda Cona et al.   XENOBIOTICA

Sequential Systemic Administrations of Combretastatin A4 Phosphate and Radioiodinated Hypericin Exert Synergistic Targeted Theranostic Effects with Prolonged Survival on SCID Mice Carrying Bifocal Tumor Xenografts

(2013) Junjie Li et al.   Theranostics

Radium-223 chloride: a potential new treatment for castration-resistant prostate cancer patients with metastatic bone disease

(2013) Harrison et al.   Cancer Management and Research

Tumor Dosimetry Using [124I]m-iodobenzylguanidine MicroPET/CT for [131I]m-iodobenzylguanidine Treatment of Neuroblastoma in a Murine Xenograft Model

(2012) Youngho Seo et al.   MOLECULAR IMAGING AND BIOLOGY

New peptide receptor radionuclide therapy of invasive cancer cells: in vivo studies using 177Lu-DOTA-AE105 targeting uPAR in human colorectal cancer xenografts

(2012) Morten Persson et al.   NUCLEAR MEDICINE AND BIOLOGY

TLR9 Agonist Protects Mice from Radiation-Induced Gastrointestinal Syndrome

(2012) Subhrajit Saha et al.   PLoS One

Exploring Theranostic Potentials of Radioiodinated Hypericin in Rodent Necrosis Models

(2012) Junjie Li et al.   Theranostics

Response, survival, and toxicity after iodine-131-metaiodobenzylguanidine therapy for neuroblastoma in preadolescents, adolescents, and adults

(2011) Alexei L. Polishchuk et al.   CANCER

Comparison of I-131 Radioimmunotherapy Tumor Dosimetry: Unit Density Sphere Model Versus Patient-Specific Monte Carlo Calculations

(2011) David M. Howard et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

Facing the Nuclear Threat: Thyroid Blocking Revisited

(2011) Heribert Hänscheid et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Biodistribution and Radiation Dosimetry of the Serotonin 5-HT6 Ligand [11C]GSK215083 Determined from Human Whole-Body PET

(2011) Robert A. Comley et al.   MOLECULAR IMAGING AND BIOLOGY

A Dual-targeting Anticancer Approach: Soil and Seed Principle

(2011) Junjie Li et al.   RADIOLOGY

Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases

(2010) Tomaz Jarm et al.   Expert Review of Anticancer Therapy

Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors

(2009) Dik J Kwekkeboom et al.   ENDOCRINE-RELATED CANCER

Hypericumin infection: Identification of anti-viral and anti-inflammatory constituents

(2009) Diane F. Birt et al.   PHARMACEUTICAL BIOLOGY

Pharmacokinetics and dosimetry of 188Re-pharmaceuticals

(2008) Guillermina Ferro-Flores et al.   ADVANCED DRUG DELIVERY REVIEWS

90Y Radioembolization for Metastatic Neuroendocrine Liver Tumors

(2008) Thomas K. Rhee et al.   ANNALS OF SURGERY

Whole-Body Biodistribution and Radiation Dosimetry of the Human Cannabinoid Type-1 Receptor Ligand 18F-MK-9470 in Healthy Subjects

(2008) K. Van Laere et al.   JOURNAL OF NUCLEAR MEDICINE